{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:00:43Z","timestamp":1775152843643,"version":"3.50.1"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,12]]},"DOI":"10.1097\/qad.0b013e32830b3a96","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T07:08:33Z","timestamp":1219820913000},"page":"1769-1778","source":"Crossref","is-referenced-by-count":45,"title":["Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy"],"prefix":"10.1097","volume":"22","author":[{"given":"Barbara","family":"Zanone Poma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cicconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Broggini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro Cozzi","family":"Lepri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mologni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella D'Arminio","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-200023010-00004","article-title":"Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?","volume":"23","author":"Behrens","year":"2000","journal-title":"Drug Saf"},{"key":"R2-11-20210130","first-page":"97","article-title":"Metabolic and morphologic complications of HIV infection","volume":"54","author":"Eid","year":"2006","journal-title":"J Med Liban"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(01)00148-6","article-title":"Metabolic complications associated with antiretroviral therapy","volume":"51","author":"Jain","year":"2001","journal-title":"Antiviral Research"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1568006054553444","article-title":"Reviewing the cardiovascular complications of HIV infection after the introduction of HAART","volume":"5","author":"Barbaro","year":"2005","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"R5-11-20210130","first-page":"5","article-title":"HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution","volume":"12","author":"Balasubramanyam","year":"2006","journal-title":"Res Initiat Treat Action"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157016206775197664","article-title":"Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection","volume":"4","author":"Barbaro","year":"2006","journal-title":"Curr HIV Res"},{"key":"R8-11-20210130","first-page":"S73","article-title":"Cardiovascular risk factors in HIV-infected patients","volume":"34","author":"Carr","year":"2003","journal-title":"JAIDS"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2003-39072","article-title":"AIDS-related lipodystrophy\/insulin resistance syndrome","volume":"35","author":"Kino","year":"2003","journal-title":"Horm Metab Res"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00273.2005","article-title":"Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy","volume":"290","author":"Hadigan","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1071\/SH04058","article-title":"Antiretroviral-therapy-associated lipoatrophy: current status and future directions","volume":"2","author":"Nolan","year":"2005","journal-title":"Sex Health"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/japplphysiol.00797.2005","article-title":"Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution","volume":"100","author":"Torriani","year":"2006","journal-title":"J Appl Physiol"},{"issue":"1 Suppl","key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jana.2006.11.011","article-title":"Current Clinical Issues Impacting the Lives of Patients Living With HIV\/AIDS","volume":"18","author":"Gallagher","year":"2007","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00126334-200209010-00007","article-title":"Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: the Swiss HIV Cohort Study","volume":"31","author":"Bernasconi","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2217\/14622416.7.4.587","article-title":"The clinical implications of antiretroviral pharmacogenomics","volume":"7","author":"Fox","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R17-11-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00041433-199508000-00004","article-title":"Triglyceride-rich lipoproteins and the progression of coronary heart disease","volume":"6","author":"Hodis","year":"1995","journal-title":"Curr Opin Lipidol"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI111711","article-title":"Modulation of lipoprotein lipase activity by apolipoproteins","volume":"75","author":"Wang","year":"1985","journal-title":"J Clin Invest"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00251-005-0031-z","article-title":"Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-na\u00efve HIV-positive patients","volume":"57","author":"Nasi","year":"2005","journal-title":"Immunogenetics"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00210629","article-title":"Transcription, adipocyte differentiation, and obesity","volume":"74","author":"Auwerx","year":"1996","journal-title":"J Mol Med"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat Genet"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0008-6363(99)00256-4","article-title":"Peroxisome proliferator-activated receptor gamma C161T polymorphism and coronary artery disease","volume":"44","author":"Wang","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R23-11-20210130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1471-4914(01)02076-7","article-title":"PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease","volume":"7","author":"Wada","year":"2001","journal-title":"Trends Mol Med"},{"key":"R24-11-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tem.2006.07.001","article-title":"Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity","volume":"17","author":"Yasuda","year":"2006","journal-title":"Trends in Endocrinol and Metab"},{"key":"R25-11-20210130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pharmtox.45.120403.095843","article-title":"Fat cells: afferent and efferent messages define new approaches to treat obesity","volume":"45","author":"Lafontan","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R26-11-20210130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1467-789x.2000.00001.x","article-title":"The sympathetic nervous system and obesity: role in aetiology and treatment","volume":"1","author":"Snitker","year":"2000","journal-title":"Obes Rev"},{"key":"R27-11-20210130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1467-789x.2001.00010.x","article-title":"The peripheral sympathetic nervous system in human obesity","volume":"2","author":"van Baak","year":"2001","journal-title":"Obes Rev"},{"key":"R28-11-20210130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199508103330605","article-title":"Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity","volume":"333","author":"Clement","year":"1995","journal-title":"N Engl J Med"},{"key":"R29-11-20210130","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1172\/JCI119854","article-title":"Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function","volume":"100","author":"Large","year":"1997","journal-title":"J Clin Invest"},{"key":"R30-11-20210130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1152\/physrev.1994.74.4.761","article-title":"Regional adiposity and morbidity","volume":"74","author":"Kissebah","year":"1994","journal-title":"Physiol Rev"},{"key":"R31-11-20210130","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1210\/jc.2003-030173","article-title":"The Gly16Arg and the Gln27Glu polymorphisms of Beta-2-adrenergic receptor are associated with metabolic syndrome in men","volume":"88","author":"Dallongeville","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-11-20210130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002030-200003310-00005","article-title":"Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients: Italian Cohort of Antiretroviral-Naive Patients","volume":"14","author":"d'Arminio Monforte","year":"2000","journal-title":"AIDS"},{"key":"R33-11-20210130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00126334-200009010-00008","article-title":"Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection","volume":"25","author":"Rezza","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-11-20210130","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/archinte.162.22.2621","article-title":"Incidence of adipose tissue alterations in first-line antiretroviral therapy","volume":"162","author":"Galli","year":"2002","journal-title":"Arch Intern Med"},{"key":"R35-11-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/rheumatology\/38.7.645","article-title":"Evaluation of a new Apo-1\/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients","volume":"38","author":"Huang","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R36-11-20210130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10038-004-0208-6","article-title":"Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians","volume":"49","author":"Garenc","year":"2004","journal-title":"J Hum Genet"},{"key":"R37-11-20210130","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1194\/jlr.M300253-JLR200","article-title":"Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease","volume":"44","author":"Olivieri","year":"2003","journal-title":"J Lipid Res"},{"key":"R38-11-20210130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/oby.2005.55","article-title":"Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity","volume":"13","author":"Ellsworth","year":"2005","journal-title":"Obes Res"},{"key":"R39-11-20210130","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1534\/genetics.104.037812","article-title":"Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans","volume":"169","author":"Zee","year":"2005","journal-title":"Genetics"},{"key":"R40-11-20210130","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-11-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002030-200501030-00002","article-title":"Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine","volume":"19","author":"McComsey","year":"2005","journal-title":"AIDS"},{"key":"R43-11-20210130","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118324","article-title":"Common genetic variation in the promoter of the human apoCIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia","volume":"96","author":"Li","year":"1995","journal-title":"J Clin Invest"},{"key":"R44-11-20210130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/CCLM.2007.140","article-title":"Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy","volume":"45","author":"Bonnet","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"R45-11-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/429295","article-title":"Modeling the influence of ApoC3, ApoE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders","volume":"191","author":"Tarr","year":"2005","journal-title":"J Inf Dis"},{"key":"R46-11-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1371\/journal.pmed.0030052","article-title":"Associations among race\/ethnicity, ApoC3 genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy","volume":"3","author":"Foulkes","year":"2006","journal-title":"Plos Medicine"},{"key":"R47-11-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/135965350601100310","article-title":"Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy","volume":"11","author":"Bard","year":"2006","journal-title":"Antivir Ther"},{"key":"R48-11-20210130","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1210\/en.2003-0985","article-title":"Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)\/IGF-I receptor autocrine circuit","volume":"145","author":"Fischer-Posovszky","year":"2004","journal-title":"Endocrinology"},{"key":"R49-11-20210130","first-page":"1183","article-title":"A functional polymorphism in fas (CD95\/APO-1) gene promoter associated with systemic lupus erythematosus","volume":"29","author":"Kanemitsu","year":"2002","journal-title":"J Rheumatol"},{"key":"R50-11-20210130","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00002030-200210180-00005","article-title":"TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy","volume":"16","author":"Maher","year":"2002","journal-title":"AIDS"},{"issue":"Suppl 1","key":"R51-11-20210130","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr","year":"2003","journal-title":"AIDS"},{"key":"R52-11-20210130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00126334-200309010-00008","article-title":"A. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns","volume":"34","author":"Galli","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R53-11-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/135965350300800412","article-title":"Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy","volume":"8","author":"Galli","year":"2003","journal-title":"Antivir Ther"},{"key":"R54-11-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJM199508103330603","article-title":"Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic receptor gene","volume":"333","author":"Walston","year":"1995","journal-title":"N Engl J Med"},{"key":"R55-11-20210130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJM199508103330604","article-title":"Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns","volume":"333","author":"Wid\u00e9n","year":"1995","journal-title":"N Engl J Med"},{"key":"R56-11-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diabetes.48.1.203","article-title":"Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function","volume":"48","author":"Hoffstedt","year":"1999","journal-title":"Diabetes"},{"key":"R57-11-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-003-0824-2","article-title":"Beta-adrenoceptor polymorphisms","volume":"369","author":"Leineweber","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R58-11-20210130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/oby.2001.102","article-title":"Association of BMI with the beta3-Adrenergic receptor gene polymorphism in japanese: meta-Analysis","volume":"9","author":"Kurokawa","year":"2001","journal-title":"Obes Res"},{"key":"R59-11-20210130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2265.2004.02183.x","article-title":"Tryptophan 64 Arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome","volume":"62","author":"P\u00e8rez-Bravo","year":"2005","journal-title":"Clin Endocrinol"},{"key":"R60-11-20210130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-200007070-00027","article-title":"Beta-3-Adrenergic receptor polymorphism and the antiretroviral therapy-related lipodystrophy syndrome","volume":"14","author":"Vonkeman","year":"2000","journal-title":"AIDS"},{"key":"R61-11-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00394-002-0363-5","article-title":"B2-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol","volume":"41","author":"Corbal\u00e1n","year":"2002","journal-title":"Eur J Nutr"},{"key":"R62-11-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2796.1999.0437e.x","article-title":"The different effects of a Gln27Glu b2-adrenoceptor gene polymorphism on obesity in males and in females","volume":"245","author":"Hellstr\u00f6m","year":"1999","journal-title":"J Intern Med"},{"key":"R64-11-20210130","first-page":"1754","article-title":"Polymorphism in the 5\u2032-leader cistron of the b2-adrenergic receptor gene associated with obesity and type 2 diabetes","volume":"84","author":"Yamada","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-11-20210130","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/jn\/133.8.2549","article-title":"Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism","volume":"133","author":"Martinez","year":"2003","journal-title":"J Nutr"},{"key":"R66-11-20210130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.HYP.37.5.1303","article-title":"Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes","volume":"37","author":"Bengtsson","year":"2001","journal-title":"Hypertension"},{"key":"R67-11-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.tpj.6500324","article-title":"beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene","volume":"5","author":"Iaccarino","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R68-11-20210130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s001250051120","article-title":"Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus","volume":"42","author":"Ishiyama-Shigemoto","year":"1999","journal-title":"Diabetologia"},{"key":"R69-11-20210130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.ijo.0802883","article-title":"Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study","volume":"29","author":"Lange","year":"2005","journal-title":"Int J Obes"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200809120-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:50:30Z","timestamp":1738345830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200809120-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,12]]},"references-count":67,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32830b3a96","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9,12]]}}}